Tumor Marker Testing Market Research Report and Forecast up to 2024 Tumor Marker Testing Market - Global Industry Anal | Page 2

pancreatic, prostatic, skin testicular cancer, leukemia, lymphoma, and others;
Clinical laboratory methods for measuring tumor markers: Abbott diagnostics’
AxSYM, Roche Diagnostics System, Fischer Thermo Scientific B.R.A.H.M.S KRYPTOR
and others; New technologies for cancer diagnostics: Monoclonal antibodies,
proteomics, new protein markers, stem cell markers, DNA microassays and others;
Clinical methods for cancer diagnosis: Screening, imaging, theranostics,
sigmoidoscopy and others.
Currently, cancer is the one of the leading causes of death in North America and
Europe. North America holds the largest share of the tumor marker testing market,
followed by Europe, due to vast discoveries and innovations for detecting cancer in
early stages. Major factors driving the tumor marker testing market in these regions
are rising incidence of cancer disease, increase in geriatric population, ongoing
research in the field of cancer detection, and improved government reimbursement
policies. However, high cost acts as a major restraint of the market.
Geographically, North America held the larger market share, followed by Europe.
High research on tumor marker and increasing number of cancer patients in these
regions are likely to boost the tumor marker testing market. However, affordability
has become a restraining factor in this market in developing regions such as Asia
Pacific and Latin America. However, the tumor marker testing market in Asia Pacific
is expected to experience strong growth.
Major players in the tumor marker testing market are Abbott Diagnostics
Affymetrix, Inc., Agilent Technologies, Inc., Beckman, Dickinson and Company
Diagnostics, BioCurex, BioModa, Inc., Clarient, Inc., Correlogic Systems,
Epigenomics AG, Gen-Probe, Inc., Hologic, Inc., Roche Diagnostics Corp.,
Veridex LLC, among others.
Ltd.,
(BD)
Inc.,
and
The report offers a comprehensive evaluation of the market. It does so via in-depth
qualitative insights, historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven research
methodologies and assumptions. By doing so, the research report serves as a
repository of analysis and information for every facet of the market, including but
not limited to: Regional markets, technology, types, and applications.
Get accurate market forecast and analysis on the Tumor Marker Testing
market. Request a sample to stay abreast on the key trends impacting this
market.
http://www.transparencymarketresearch.com/sample/sample.php?
flag=B&rep_id=2253
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics